BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5460847)

  • 1. Altered dihydrofolate reductase associated with drug-resistance transfer between rodent plasmodia.
    Ferone R; O'Shea M; Yoeli M
    Science; 1970 Feb; 167(3922):1263-4. PubMed ID: 5460847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered dihydrofolate reductase associated with a pyrimethamine-resistant Plasmodium berghei berghei produced in a single step.
    Diggens SM; Gutteridge WE; Trigg PI
    Nature; 1970 Nov; 228(5271):579-80. PubMed ID: 5472487
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-resistance transfer among rodent plasmodia. 1. Acquisition of resistance to pyrimethamine by a drug-sensitive strain of Plasmodium berghei in the course of its concomitant development with a pyrimethamine-resistant P. vinckei strain.
    Yoeli M; Upmanis RS; Most H
    Parasitology; 1969 May; 59(2):429-47. PubMed ID: 5770077
    [No Abstract]   [Full Text] [Related]  

  • 4. Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei.
    Ferone R
    J Biol Chem; 1970 Feb; 245(4):850-4. PubMed ID: 5418106
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of pyrimethamine resistance in Plasmodium falciparum.
    Dieckmann A; Jung A
    Parasitology; 1986 Oct; 93 ( Pt 2)():275-8. PubMed ID: 3537922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered dihydrofolate reductase in pyrimethamine-resistant Plasmodium falciparum.
    Walter RD
    Mol Biochem Parasitol; 1986 Apr; 19(1):61-6. PubMed ID: 3520313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.
    Sirawaraporn W; Yuthavong Y
    Mol Biochem Parasitol; 1984 Mar; 10(3):355-67. PubMed ID: 6727925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of rodent malaria: transfer of resistance vs mutation.
    Schoenfeld C; Most H; Entner N
    Exp Parasitol; 1974 Oct; 36(2):265-77. PubMed ID: 4606333
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.
    Sirawaraporn W; Yuthavong Y
    Antimicrob Agents Chemother; 1986 May; 29(5):899-905. PubMed ID: 3729346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance.
    Cheng Q; Saul A
    Mol Biochem Parasitol; 1994 Jun; 65(2):361-3. PubMed ID: 7969277
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro.
    Sandefur CI; Wooden JM; Quaye IK; Sirawaraporn W; Sibley CH
    Mol Biochem Parasitol; 2007 Jul; 154(1):1-5. PubMed ID: 17451822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum.
    Chen GX; Mueller C; Wendlinger M; Zolg JW
    Mol Pharmacol; 1987 Apr; 31(4):430-7. PubMed ID: 3553892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
    Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum: induction, selection, and characterization of pyrimethamine-resistant mutants.
    Banyal HS; Inselburg J
    Exp Parasitol; 1986 Aug; 62(1):61-70. PubMed ID: 3522262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum.
    McCutchan TF; Welsh JA; Dame JB; Quakyi IA; Graves PM; Drake JC; Allegra CJ
    Antimicrob Agents Chemother; 1984 Nov; 26(5):656-9. PubMed ID: 6393866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei.
    Janse CJ; Ramesar J; Waters AP
    Nat Protoc; 2006; 1(1):346-56. PubMed ID: 17406255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on dihydrofolate reductases from Plasmodium falciparum and Aotus trivirgatus.
    Kan SC; Siddiqui WA
    J Protozool; 1979 Nov; 26(4):660-4. PubMed ID: 44526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine hydroxymethyltransferase from pyrimethamine-sensitive and -resistant strains of Plasmodium chabaudi.
    Ruenwongsa P; Luanvararat M; O'Sullivan WJ
    Mol Biochem Parasitol; 1989 Mar; 33(3):265-71. PubMed ID: 2495446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.